Advanced Science· 2026Q1
Mitochondrial Protection and Neural Repair via ROS‐Responsive Biomimetic Nanoparticles in Intracerebral Hemorrhage
- 0citations
- Q1SCImago
- 2026year
Short summary
Biomimetic nanoparticles (NP@D+M) co-delivering DIDS and Mdivi-1 protected neurons and improved outcomes in intracerebral hemorrhage (ICH) models by disrupting LPAR1-VDAC1 interaction and restoring mitochondrial homeostasis.
AI-generated from the title and abstract; the full text is not read.
Key points
- Developed ROS-responsive biomimetic nanoparticles (NP@D+M) for co-delivery of DIDS and Mdivi-1.
- NP@D+M enhanced neuronal uptake, protected neurites, reduced cell death, and restored mitochondrial function in ICH models.
- The nanoparticles disrupted the LPAR1-VDAC1 interaction, inhibited mPTP opening, and restored mitochondrial homeostasis.
- In vivo studies showed NP@D+M crossed the BBB, protected neurons, and alleviated neurological deficits without significant toxicity.
AI-generated from the title and abstract; the full text is not read.
Abstract
ABSTRACT Intracerebral hemorrhage (ICH)‐induced secondary brain injury is driven in part by oxidative stress, blood‐brain barrier disruption, mitochondrial dysfunction, and neuronal loss. Here, we developed a brain endothelial cell membrane‐coated ROS‐responsive biomimetic nanoplatform (NP@D+M) for co‐delivery of the VDAC1 inhibitor DIDS and the mitochondrial fission inhibitor Mdivi‐1. NP@D+M showed uniform size, preserved endothelial membrane proteins, and accelerated drug release under elevated H2O2. In ICH‐like neuronal injury models, NP@D+M enhanced uptake, protected neurites, reduced LDH release and apoptosis, restored mitochondrial membrane potential and ATP production, and suppressed mitochondrial ROS. Mechanistically, NP@D+M disrupted aberrant LPAR1‐VDAC1 interaction, inhibited mPTP opening, and restored mitochondrial homeostasis; LPAR1 gain‐ and loss‐of‐function experiments confirmed its role in the mitochondrial protective effect. Targeted metabolomics and single‐cell transcriptomics further supported improved energy metabolism and attenuated injury‐associated cellular responses. In vivo, NP@D+M crossed the BBB, accumulated in brain parenchyma, protected perihematomal neurons, improved mitochondrial function, and alleviated neurological and cognitive deficits without obvious systemic toxicity. These findings identify a LPAR1‐VDAC1‐mPTP‐targeted nanotherapeutic strategy for mitochondrial protection and neural repair after ICH.
The authors' abstract, as published at the source. Advanced Science, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biomaterials
BiomaterialsMaterials Science